Skip to content

High Flow vs Conventional Oxygen in Head and Neck Surgery

Prevention of Pulmonary Complications Using High Flow With Tracheostomy Interface vs Conventional Oxygen Therapy in Patients After Major Head and Neck Surgery: Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05362526
Enrollment
56
Registered
2022-05-05
Start date
2022-07-01
Completion date
2024-07-01
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease

Keywords

Head neck surgery, heated humidification, cool humidification

Brief summary

Patients undergoing major head and neck surgery are at risk for postoperative pulmonary complications. The goal of this randomized clinical trial is to evaluate the effectiveness of high flow heated humidified oxygen at preventing postoperative pulmonary complications after major head and neck surgery, when compared to conventional oxygen therapy (aerosol cool mist).

Detailed description

Participants enrolled in this study are randomly assigned to receive either conventional oxygen therapy (aerosol cool mist) or heated humidified high flow oxygen via the trach after head and neck surgery. The study team then collects information regarding clinical outcomes to explore if there are differences between the two groups.

Interventions

High flow is for the treatment of spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases. The subjects in this group will receive HFOT at a flow rate of 60-30 liters per minute, maximum concentration of 40%, which will be titrated by bedside nurse to maintain an oxygen saturation of 92% or greater (unless there is a history of COPD and then the clinician can recommend \>88%)

DEVICEConventional cool mist aerosol humidification

Subjects will be placed on aerosolized trach mask with cool humidification, and titrated to keep oxygen saturation \>92% (unless there is a history of COPD and then the clinician can recommend \>88%)

Sponsors

Fisher and Paykel Healthcare
CollaboratorINDUSTRY
University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing major head and neck surgery that includes any neck dissection * Major head and neck surgery is defined as having a mean length of stay of three or more days, based on the diagnosis \[14\] * Surgery requires an elective tracheostomy for airway protection or laryngectomy tube in the case of total laryngectomy

Exclusion criteria

* \<18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Proportion of Patients With Post-operative Pulmonary ComplicationDay 14Postoperative pulmonary complication will be defined as: * Atelectasis or infiltrate diagnosed by radiologist on any postoperative chest radiograph within first 14 days or discharge (whichever occurs first) * Pneumonia Diagnosis is suggested by a history of cough, dyspnea, pleuritic pain, or acute functional or cognitive decline, with abnormal vital signs (e.g., fever, tachycardia) and lung examination findings. Diagnosis should be confirmed by chest radiography or ultrasonography. \[15\] * Chronic pulmonary obstructive disease exacerbation An event in the natural course of the disease characterized by a change in the patient's baseline dyspnea, cough, and/or sputum and beyond normal day-to-day variations, that is acute in onset and may warrant a change in regular medication in a patient with underlying COPD \[16\] * Adult respiratory distress syndrome (Berlin definition) * Need for mechanical ventilation * Need for non-invasive mechanical ventilation

Secondary

MeasureTime frameDescription
Percentage of Patients Decannulated35 daysNumber of patients who were decannulated prior to discharge.
Hospital Length of Stay35 daysNumber of days from admission to hospital discharge.

Countries

United States

Participant flow

Recruitment details

56 consented and randomized.

Participants by arm

ArmCount
HFOT (High Flow With Tracheostomy Interface)
Patient will be placed on heated humidified high flow after surgery. High flow humidification: High flow is for the treatment of spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases. The subjects in this group will receive HFOT at a flow rate of 60-30L liters per minute, maximum concentration of 40%, which will be titrated by bedside nurse to maintain an oxygen saturation of 92% or greater (unless there is a history of COPD and then the clinician can recommend \>88%)
24
COT (Conventional Oxygen Therapy)
Pt will be placed on conventional oxygen therapy after surgery. Conventional cool mist aerosol humidification: Subjects will be placed on aerosolized trach mask with cool humidification, and titrated to keep oxygen saturation \>92% (unless there is a history of COPD and then the clinician can recommend \>88%)
25
Total49

Baseline characteristics

CharacteristicHFOT (High Flow With Tracheostomy Interface)COT (Conventional Oxygen Therapy)Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
5 Participants15 Participants20 Participants
Age, Categorical
Between 18 and 65 years
19 Participants10 Participants29 Participants
Age, Continuous56.1 years
STANDARD_DEVIATION 13.5
66.8 years
STANDARD_DEVIATION 9.2
61.57 years
STANDARD_DEVIATION 12.56
Body mass index26.7 kilograms per square meter
STANDARD_DEVIATION 8.9
26.2 kilograms per square meter
STANDARD_DEVIATION 6.8
26.469 kilograms per square meter
STANDARD_DEVIATION 7.83
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
24 participants25 participants49 participants
Sex: Female, Male
Female
11 Participants7 Participants18 Participants
Sex: Female, Male
Male
13 Participants18 Participants31 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 240 / 25
other
Total, other adverse events
0 / 240 / 25
serious
Total, serious adverse events
1 / 240 / 25

Outcome results

Primary

Proportion of Patients With Post-operative Pulmonary Complication

Postoperative pulmonary complication will be defined as: * Atelectasis or infiltrate diagnosed by radiologist on any postoperative chest radiograph within first 14 days or discharge (whichever occurs first) * Pneumonia Diagnosis is suggested by a history of cough, dyspnea, pleuritic pain, or acute functional or cognitive decline, with abnormal vital signs (e.g., fever, tachycardia) and lung examination findings. Diagnosis should be confirmed by chest radiography or ultrasonography. \[15\] * Chronic pulmonary obstructive disease exacerbation An event in the natural course of the disease characterized by a change in the patient's baseline dyspnea, cough, and/or sputum and beyond normal day-to-day variations, that is acute in onset and may warrant a change in regular medication in a patient with underlying COPD \[16\] * Adult respiratory distress syndrome (Berlin definition) * Need for mechanical ventilation * Need for non-invasive mechanical ventilation

Time frame: Day 14

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
HFOT (High Flow With Tracheostomy Interface)Proportion of Patients With Post-operative Pulmonary Complication2 Participants
COT (Conventional Oxygen Therapy)Proportion of Patients With Post-operative Pulmonary Complication11 Participants
Secondary

Hospital Length of Stay

Number of days from admission to hospital discharge.

Time frame: 35 days

ArmMeasureValue (MEAN)Dispersion
HFOT (High Flow With Tracheostomy Interface)Hospital Length of Stay10.125 daysStandard Deviation 6.2
COT (Conventional Oxygen Therapy)Hospital Length of Stay10.88 daysStandard Deviation 6.3
Secondary

Percentage of Patients Decannulated

Number of patients who were decannulated prior to discharge.

Time frame: 35 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
HFOT (High Flow With Tracheostomy Interface)Percentage of Patients Decannulated18 Participants
COT (Conventional Oxygen Therapy)Percentage of Patients Decannulated23 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026